Skip to main content
Top
Published in: Cancer Causes & Control 12/2014

01-12-2014 | Original paper

Age of diagnosing physician impacts the incidence of thyroid cancer in a population

Authors: Sapna Nagar, Briseis Aschebrook-Kilfoy, Edwin L. Kaplan, Peter Angelos, Raymon H. Grogan

Published in: Cancer Causes & Control | Issue 12/2014

Login to get access

Abstract

Background

Thyroid ultrasound and fine-needle aspiration (FNA) have been implicated in the overdiagnosis of thyroid cancer. To study how the use of diagnostic tools impacts thyroid cancer incidence, we propose using physician age as a surrogate. We aimed to determine whether thyroid cancer incidence is higher in areas with a high density of young physicians compared with areas with a high density of older physicians.

Methods

SEER 13 database was used to determine thyroid cancer incidence. These data were linked to the Area Resource File data (2000), containing information on physician age at a county-specific level. Cohorts were divided by age based on the concentration of physicians within a population of 1,000,000 persons. The study period was divided into two time periods (1992–1995, 2006–2009).

Results

The incidence of thyroid cancer was stable in areas with high concentrations of young and older physicians during the 1992–1995 time period [<35: 5.97; 55–64: 6.82; ≥65: 6.70 (per 100,000py)]. Areas with high concentrations of young physicians had an increased incidence of thyroid cancer compared with areas of high concentrations of older physicians during the 2006–2009 period [<35: 13.3; 55–64: 9.86; ≥65: 7.47 (per 100,000py)].

Conclusions

Thyroid cancer incidence was lower in areas with high concentrations of older physicians. This may be the result of increased adoption of thyroid ultrasound and FNA among younger physicians who have trained after diagnostic tools became common. Age of the diagnosing physician is a surrogate for diagnostic utility contributing to thyroid cancer trends.
Literature
1.
go back to reference Swaminathan R, Shanta V, Ferlay J, Balasubramanian S, Bray F, Sankaranarayanan R (2011) Trends in cancer incidence in Chennai city (1982–2006) and statewide predictions of future burden in Tamil Nadu (2007–16) Swaminathan R, Shanta V, Ferlay J, Balasubramanian S, Bray F, Sankaranarayanan R (2011) Trends in cancer incidence in Chennai city (1982–2006) and statewide predictions of future burden in Tamil Nadu (2007–16)
2.
go back to reference Kilfoy BA, Zheng T, Holford TR, Han X, Ward MH, Sjodin A et al (2009) International patterns and trends in thyroid cancer incidence, 1973–2002. Cancer Causes Control 20(5):525–531PubMedCentralPubMedCrossRef Kilfoy BA, Zheng T, Holford TR, Han X, Ward MH, Sjodin A et al (2009) International patterns and trends in thyroid cancer incidence, 1973–2002. Cancer Causes Control 20(5):525–531PubMedCentralPubMedCrossRef
3.
go back to reference Aschebrook-Kilfoy B, Schechter RB, Shih YC, Kaplan EL, Chiu BC, Angelos P, Grogan RH (2013) The clinical and economic burden of a sustained increase in thyroid cancer incidence. Cancer Epidemiol Biomarkers Prev 22(7):1252–1259PubMedCrossRef Aschebrook-Kilfoy B, Schechter RB, Shih YC, Kaplan EL, Chiu BC, Angelos P, Grogan RH (2013) The clinical and economic burden of a sustained increase in thyroid cancer incidence. Cancer Epidemiol Biomarkers Prev 22(7):1252–1259PubMedCrossRef
4.
go back to reference Reynolds RM, Weir J, Stockton DL, Brewster DH, Sandeep TC, Strachan MW (2005) Changing trends in incidence and mortality of thyroid cancer in Scotland. Clin Endocrinol (Oxf) 62(2):156–162CrossRef Reynolds RM, Weir J, Stockton DL, Brewster DH, Sandeep TC, Strachan MW (2005) Changing trends in incidence and mortality of thyroid cancer in Scotland. Clin Endocrinol (Oxf) 62(2):156–162CrossRef
5.
go back to reference Olaleye O, Ekrikpo U, Moorthy R, Lyne O, Wiseberg J, Black M, Mitchell D (2011) Increasing incidence of differentiated thyroid cancer in South East England: 1987–2006. Eur Arch Otorhinolaryngol 268(6):899–906PubMedCrossRef Olaleye O, Ekrikpo U, Moorthy R, Lyne O, Wiseberg J, Black M, Mitchell D (2011) Increasing incidence of differentiated thyroid cancer in South East England: 1987–2006. Eur Arch Otorhinolaryngol 268(6):899–906PubMedCrossRef
6.
go back to reference Davies L, Welch HG (2006) Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA 295(18):2164–2167PubMedCrossRef Davies L, Welch HG (2006) Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA 295(18):2164–2167PubMedCrossRef
7.
go back to reference Ramírez-Vick M, Nieves-Rodríguez M, Lúgaro-Gómez A, Pérez-Irizarry J (2011) Increasing incidence of thyroid cancer in Puerto Rico, 1985–2004. P R Health Sci J 30(3):109–115 Ramírez-Vick M, Nieves-Rodríguez M, Lúgaro-Gómez A, Pérez-Irizarry J (2011) Increasing incidence of thyroid cancer in Puerto Rico, 1985–2004. P R Health Sci J 30(3):109–115
8.
go back to reference Yu G-P, Li JC-L, Branovan D, McCormick S, Schantz SP (2010) Thyroid cancer incidence and survival in the national cancer institute surveillance, epidemiology, and end results race/ethnicity groups. Thyroid 20(5):465–473PubMedCrossRef Yu G-P, Li JC-L, Branovan D, McCormick S, Schantz SP (2010) Thyroid cancer incidence and survival in the national cancer institute surveillance, epidemiology, and end results race/ethnicity groups. Thyroid 20(5):465–473PubMedCrossRef
9.
go back to reference Kahn C, Simonella L, Sywak M, Boyages S, Ung O, O’Connell D (2012) Postsurgical pathology reporting of thyroid cancer in New South Wales, Australia. Thyroid 22(6):604–610PubMedCrossRef Kahn C, Simonella L, Sywak M, Boyages S, Ung O, O’Connell D (2012) Postsurgical pathology reporting of thyroid cancer in New South Wales, Australia. Thyroid 22(6):604–610PubMedCrossRef
10.
go back to reference Karakoc D, Erol T, Memmedova B, Memis A, Sayek I (2009) Thyroid surgery: what has changed from (1970 to 2004): a Turkish perspective. Am J Surg 198(1):12–16PubMedCrossRef Karakoc D, Erol T, Memmedova B, Memis A, Sayek I (2009) Thyroid surgery: what has changed from (1970 to 2004): a Turkish perspective. Am J Surg 198(1):12–16PubMedCrossRef
11.
go back to reference Davies L, Welch HG (2014) Current thyroid cancer trends in the United States. JAMA Otolaryngol Head Neck Surg Feb: Epub ahead of print Davies L, Welch HG (2014) Current thyroid cancer trends in the United States. JAMA Otolaryngol Head Neck Surg Feb: Epub ahead of print
12.
go back to reference Sosa JA, Hanna JW, Robinson KA, Lanman RB (2013) Increases in thyroid nodule fine-needle aspirations, operations, and diagnoses of thyroid cancer in the United States. Surgery 154(6):1420–1426 discussion 1426-1427PubMedCrossRef Sosa JA, Hanna JW, Robinson KA, Lanman RB (2013) Increases in thyroid nodule fine-needle aspirations, operations, and diagnoses of thyroid cancer in the United States. Surgery 154(6):1420–1426 discussion 1426-1427PubMedCrossRef
13.
go back to reference Udelsman R, Zhang Y (2014) The epidemic of thyroid cancer in the United States: the role of endocrinologists and ultrasounds. Thyroid 24(3):472–479PubMedCrossRef Udelsman R, Zhang Y (2014) The epidemic of thyroid cancer in the United States: the role of endocrinologists and ultrasounds. Thyroid 24(3):472–479PubMedCrossRef
14.
go back to reference Sprague BL, Warren Andersen S, Trentham-Dietz A (2008) Thyroid cancer incidence and socioeconomic indicators of health care access. Cancer Causes Control 19(6):585–593PubMedCrossRef Sprague BL, Warren Andersen S, Trentham-Dietz A (2008) Thyroid cancer incidence and socioeconomic indicators of health care access. Cancer Causes Control 19(6):585–593PubMedCrossRef
15.
go back to reference Li N, Du XL, Reitzel LR, Xu L, Sturgis EM (2013) Impact of enhanced detection on the increase in thyroid cancer incidence in the United States: review of incidence trends by socioeconomic status within the surveillance, epidemiology, and end results registry, 1980–2008. Thyroid 23(1):103–110PubMedCentralPubMedCrossRef Li N, Du XL, Reitzel LR, Xu L, Sturgis EM (2013) Impact of enhanced detection on the increase in thyroid cancer incidence in the United States: review of incidence trends by socioeconomic status within the surveillance, epidemiology, and end results registry, 1980–2008. Thyroid 23(1):103–110PubMedCentralPubMedCrossRef
16.
go back to reference Kim JM, Kim H-M, Jung B-Y, Park E-C, Cho W-H, Lee SG (2012) The association between cancer incidence and family income: analysis of Korean national health insurance cancer registration data. Asian Pac J Cancer Prev 13(4):1371–1376PubMedCrossRef Kim JM, Kim H-M, Jung B-Y, Park E-C, Cho W-H, Lee SG (2012) The association between cancer incidence and family income: analysis of Korean national health insurance cancer registration data. Asian Pac J Cancer Prev 13(4):1371–1376PubMedCrossRef
17.
go back to reference Lim II, Hochman T, Blumberg SN, Patel KN, Heller KS, Ogilvie JB (2012) Disparities in the initial presentation of differentiated thyroid cancer in a large public hospital and adjoining university teaching hospital. Thyroid 22(3):269–274PubMedCentralPubMedCrossRef Lim II, Hochman T, Blumberg SN, Patel KN, Heller KS, Ogilvie JB (2012) Disparities in the initial presentation of differentiated thyroid cancer in a large public hospital and adjoining university teaching hospital. Thyroid 22(3):269–274PubMedCentralPubMedCrossRef
18.
go back to reference Decker SL, Jamoom EW, Sisk JE (2012) Physicians in nonprimary care and small practices and those age 55 and older lag in adopting electronic health record systems. Health Aff (Millwood) 31(5):1108–11014CrossRef Decker SL, Jamoom EW, Sisk JE (2012) Physicians in nonprimary care and small practices and those age 55 and older lag in adopting electronic health record systems. Health Aff (Millwood) 31(5):1108–11014CrossRef
19.
go back to reference Freiman MP (1985) The rate of adoption of new procedures among physicians: the impact of specialty and practice characteristics. Medical Care 23(8):939-945 Freiman MP (1985) The rate of adoption of new procedures among physicians: the impact of specialty and practice characteristics. Medical Care 23(8):939-945
20.
go back to reference Hlatky MA, Cotugno H, O’Connor C, Mark DB, Pryor DB, Califf RM (1988) Adoption of thrombolytic therapy in the management of acute myocardial infarction. Am J Cardiol 61(8):510–514PubMedCrossRef Hlatky MA, Cotugno H, O’Connor C, Mark DB, Pryor DB, Califf RM (1988) Adoption of thrombolytic therapy in the management of acute myocardial infarction. Am J Cardiol 61(8):510–514PubMedCrossRef
21.
go back to reference Levine RA (2012) History of thyroid ultrasound. In: Baskin HJ, Duick DS, Levine RA (eds) Thyroid ultrasound and ultrasound-guided FNA (3rd edition:1–8). Springer, Berlin Levine RA (2012) History of thyroid ultrasound. In: Baskin HJ, Duick DS, Levine RA (eds) Thyroid ultrasound and ultrasound-guided FNA (3rd edition:1–8). Springer, Berlin
22.
go back to reference Fujimoto Y, Oka A, Omoto R, Hirose M (1967) Ultrasound scanning of the thyroid gland as a new diagnostic approach. Ultrasonics 5(3):177–180PubMedCrossRef Fujimoto Y, Oka A, Omoto R, Hirose M (1967) Ultrasound scanning of the thyroid gland as a new diagnostic approach. Ultrasonics 5(3):177–180PubMedCrossRef
23.
go back to reference Walfish PG, Hazani E, Strawbridge HT, Miskin M, Rosen IB (1977) Combined ultrasound and needle aspiration cytology in the assessment and management of hypofunctioning thyroid nodule. Ann Intern Med 87(3):270–274PubMedCrossRef Walfish PG, Hazani E, Strawbridge HT, Miskin M, Rosen IB (1977) Combined ultrasound and needle aspiration cytology in the assessment and management of hypofunctioning thyroid nodule. Ann Intern Med 87(3):270–274PubMedCrossRef
24.
go back to reference Gharib H, Goellner JR (1993) Fine-needle aspiration biopsy of the thyroid: an appraisal. Ann Intern Med 118(4):282–289PubMedCrossRef Gharib H, Goellner JR (1993) Fine-needle aspiration biopsy of the thyroid: an appraisal. Ann Intern Med 118(4):282–289PubMedCrossRef
25.
go back to reference Desforges JF, Mazzaferri EL (1993) Management of a solitary thyroid nodule. N Engl J Med 328(8):553–559CrossRef Desforges JF, Mazzaferri EL (1993) Management of a solitary thyroid nodule. N Engl J Med 328(8):553–559CrossRef
26.
go back to reference Surveillance, epidemiology, and end results (SEER) program (November 2008 submission). Surveillance Research Program, Cancer Statistics Branch 2009, Apr Surveillance, epidemiology, and end results (SEER) program (November 2008 submission). Surveillance Research Program, Cancer Statistics Branch 2009, Apr
27.
go back to reference World health oraganization. International code for diseases in oncology. (2000); 3rd Edition World health oraganization. International code for diseases in oncology. (2000); 3rd Edition
30.
go back to reference Singer PA, Cooper DS, Daniels GH, Ladenson PW, Greenspan FS, Levy EG et al (1996) Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer. Arch Intern Med 156(19):2165–2172PubMedCrossRef Singer PA, Cooper DS, Daniels GH, Ladenson PW, Greenspan FS, Levy EG et al (1996) Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer. Arch Intern Med 156(19):2165–2172PubMedCrossRef
31.
go back to reference Oehlert GW (1992) A note on the delta method. Am Stat 46(1):27–29 Oehlert GW (1992) A note on the delta method. Am Stat 46(1):27–29
Metadata
Title
Age of diagnosing physician impacts the incidence of thyroid cancer in a population
Authors
Sapna Nagar
Briseis Aschebrook-Kilfoy
Edwin L. Kaplan
Peter Angelos
Raymon H. Grogan
Publication date
01-12-2014
Publisher
Springer International Publishing
Published in
Cancer Causes & Control / Issue 12/2014
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-014-0467-2

Other articles of this Issue 12/2014

Cancer Causes & Control 12/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine